222 related articles for article (PubMed ID: 7387177)
1. Epidermal thinning: evaluation of commercial corticosteroids.
Wrench R
Arch Dermatol Res; 1980; 267(1):7-24. PubMed ID: 7387177
[TBL] [Abstract][Full Text] [Related]
2. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
Norris JF; Ilderton E; Yardley HJ; Summerly R; Forster S
Br J Dermatol; 1984 Jul; 111 Suppl 27():195-203. PubMed ID: 6743552
[TBL] [Abstract][Full Text] [Related]
3. Bio-assay of corticosteroids for topical application.
Spearman RI; Jarrett A
Br J Dermatol; 1975 May; 92(5):581-4. PubMed ID: 1174471
[TBL] [Abstract][Full Text] [Related]
4. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
Winter GD; Wilson L
Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065
[TBL] [Abstract][Full Text] [Related]
5. The dilution of proprietary corticosteroid ointments--an attempt to evaluate relative clinical potencies.
Gibson JR; Darley C; Kirsch J; Saihan EM; Neild VS
Br J Dermatol; 1982 Apr; 106(4):445-7. PubMed ID: 7073968
[TBL] [Abstract][Full Text] [Related]
6. Halogenation and topical corticosteroids: a comparison between the 17-butyrate esters of hydrocortisone and clobetasone in ointment bases.
Allenby CF; Sparkes CG
Br J Dermatol; 1981 Feb; 104(2):179-83. PubMed ID: 7011356
[TBL] [Abstract][Full Text] [Related]
7. 0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects.
Kerscher MJ; Korting HC; Mehringer L; Mätzig R
Skin Pharmacol; 1996; 9(2):120-3. PubMed ID: 8722606
[TBL] [Abstract][Full Text] [Related]
8. An improved method of assessing topical corticosteroid activity.
Barnes H; Gaylarde PM; Brock AP; Sarkany I
Br J Dermatol; 1975 Oct; 93(4):459-64. PubMed ID: 1201192
[TBL] [Abstract][Full Text] [Related]
9. The effects of topical and systemic glucocorticosteroids on DNA synthesis in different tissues of the hairless mouse.
Marshall RC; Burrows M; Brookes LG; du Vivier A
Br J Dermatol; 1981 Nov; 105(5):517-20. PubMed ID: 7295568
[TBL] [Abstract][Full Text] [Related]
10. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
Glade CP; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
[TBL] [Abstract][Full Text] [Related]
11. A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses.
Uliasz A; Zeichner J; Soung J; Wong V; Lebwohl M
Cutis; 2008 Jun; 81(6):517-9. PubMed ID: 18666395
[TBL] [Abstract][Full Text] [Related]
12. Objective measurement of topically applied corticosteroids.
Király K; Soós G
Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of topical steroids in the control of radiation dermatitis: a randomised trial using 1% hydrocortisone cream and 0.05% clobetasone butyrate (Eumovate).
Glees JP; Mameghan-Zadeh H; Sparkes CG
Clin Radiol; 1979 Jul; 30(4):397-403. PubMed ID: 380872
[TBL] [Abstract][Full Text] [Related]
14. Penetration of various corticosteroids through epidermis in vitro.
Ponec M; Polano MK
Arch Dermatol Res; 1979 May; 265(1):101-4. PubMed ID: 475440
[TBL] [Abstract][Full Text] [Related]
15. A transgenic mouse model provides a novel biological assay of topical glucocorticosteroid potency.
Katchman SD; Del Monaco M; Wu M; Brown D; Hsu-Wong S; Uitto J
Arch Dermatol; 1995 Nov; 131(11):1274-8. PubMed ID: 7503571
[TBL] [Abstract][Full Text] [Related]
16. Eumovate (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety.
Goustas P; Cork MJ; Higson D
J Dermatolog Treat; 2003 Jun; 14(2):71-85. PubMed ID: 12775314
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the potencies of several diluted and undiluted corticosteroid preparations using the vasoconstrictor assay.
Kirsch J; Gibson JR; Darley CR; Burke CA
Dermatologica; 1983; 167(3):138-41. PubMed ID: 6195026
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.
Ong JT; Poulsen BJ; Akers WA; Scholtz JR; Genter FC; Kertesz DJ
Arch Dermatol; 1989 Dec; 125(12):1662-5. PubMed ID: 2589861
[TBL] [Abstract][Full Text] [Related]
19. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
Priestley GC
Br J Dermatol; 1978 Sep; 99(3):253-61. PubMed ID: 81679
[TBL] [Abstract][Full Text] [Related]
20. The effects on epidermal DNA synthesis of the butyrate esters of clobetasone and clobetasol, and the propionate ester of clobetasol.
Marshall RC; Du Vivier A
Br J Dermatol; 1978 Mar; 98(3):355-9. PubMed ID: 638042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
